Cargando…
Circulating Activin A predicts survival in cancer patients
BACKGROUND: Several experimental evidences pinpoint the possible role of Activin A (ActA) as a driver of cancer cachexia. Supporting this hypothesis, we showed recently that human cancer cachexia is associated with high ActA levels. Moreover, ActA levels were correlated with body weight loss and ske...
Autores principales: | Loumaye, Audrey, de Barsy, Marie, Nachit, Maxime, Lause, Pascale, van Maanen, Aline, Trefois, Pierre, Gruson, Damien, Thissen, Jean‐Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659049/ https://www.ncbi.nlm.nih.gov/pubmed/28712119 http://dx.doi.org/10.1002/jcsm.12209 |
Ejemplares similares
-
Abdominal Fat and Muscle Measurement on Routine CT: Is It Useful?
por: Nachit, Maxime, et al.
Publicado: (2016) -
Activin A Causes Muscle Atrophy through MEF2C-Dependent Impaired Myogenesis
por: Loumaye, Audrey, et al.
Publicado: (2022) -
SAT670 Is Myostatin A Biomarker Of Skeletal Muscle Mass?
por: Orioli, Laura, et al.
Publicado: (2023) -
p21-Activated Kinase 1 Is Permissive for the Skeletal Muscle Hypertrophy Induced by Myostatin Inhibition
por: Barbé, Caroline, et al.
Publicado: (2021) -
Marked Increased Production of Acute Phase Reactants by Skeletal Muscle during Cancer Cachexia
por: Massart, Isabelle S., et al.
Publicado: (2020)